Absorption and Tolerability of Injectable Administration of Niagen®+, as Compared to NAD+
Recruiting now · Not applicable · Has a placebo group
Conditions studied: Healthy Aging
In brief
This study evaluates the subjective effects of injection administration of NR on healthy adult populations.
Key facts
- Study ID
- NCT06919328
- Run by
- Nutraceuticals Research Institute
- People needed
- 70
- Starts
- 2024-10-31
- Expected to finish
- 2025-06-30
- Last updated by the study team
- 2025-04-09
Who can join
Age: 40 and older, up to 65. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Provision of signed and dated informed consent form
- Stated willingness and demonstrated ability to comply with all study procedures, as well as availability for the duration of the study
- Lives within 100 miles of the NRI study site
- Any gender, aged 40-65, inclusive
- Good general health as evidenced by medical history
- BMI 25-34.9 kg/m2
- Sedentary behavior (defined as <20 minutes per day or 100 minutes per week of moderate to vigorous exercise)
- Demonstrated fatigue (Fatigue Assessment Scale) defined as a below-average score
- For females of reproductive potential: use of highly effective contraception for at least 1 month prior to screening and agreement to use such a method during study participation and for an additional month after the end of the study
- Agreement to adhere to Lifestyle Considerations throughout study duration
You may not qualify if…
- Current diagnosis of any seizure disorder, diabetes or insulin resistance, any kidney or liver disorder, heart disease, anemia, cancer, or Parkinson's disease
- ANY chronic illness (pre-disease state acceptable)
- Out of range phosphate levels at baseline
- BMI less than 25 or greater than or equal to 35
- Pregnancy, trying to conceive, or breastfeeding
- Known allergic reactions to any components of the intervention or related compounds, including any form of B3
- Positive COVID-19 test within 30 days of the study period
- Recent dramatic weight changes (10% change in body weight in the last 6 months)
- Existing usage of a NAD+ or NAD precursor supplement in any form (oral, nasal, patch, or injection/IV administration), including a B-complex supplement, within 60 days of the study, not including multivitamins.
- Introducing a new medication, supplement, investigational drug, or other intervention (including lifestyle changes) within 60 days of the start of the study.
Where it is running
- Nutraceuticals Research Institute — Huntsville, Alabama, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.